🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

[The effect of neuroprotectors on the level of BDNF, tumor necrosis factor alpha and apoptosis markers, and in acute cerebrovascular accidents].

PMID: 41782540 · DOI: 10.17116/jnevro2026126021123 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2026 · A V Shchulkin, I V Chernykh, Y V Abalenikhina, M V Gatsanoga, D L Kochetkova, N A Kruzhalov, E V Krestinina, E N Yakushe
📄 Abstract

To compare the effects of Mexidol, Cerebrolysin, and Cortexin on the levels of brain-derived neurotrophic factor (BDNF), tumor necrosis factor-alpha (TNF The study was performed on male Wistar rats. Right MCA occlusion-reperfusion was modeled using the method of J. Koizumi (1986). The occlusion duration was 60 minutes (1 hour). At the onset of reperfusion, animals were administered a single intravenous injection of either saline (control), or Mexidol (ethylmethylhydroxypyridine succinate) intravenously at a dose of 50 mg/kg, or Cerebrolysin intraperitoneally at a dose of 215 mg/kg, or Cortexin intraperitoneally at a dose of 1 mg/kg. Twenty-four hours after the start of reperfusion, the brain lesion volume was analyzed after staining with a 1% solution of 2.3,5-triphenyltetrazolium chloride. Western blotting was used to assess the levels of BDNF, TNF In the MCA occlusion-reperfusion model, the necrosis volume in the affected hemisphere of control animals was 38.16±5.98%. Mexidol reduced the necrosis volume to 20.48±2.33% ( Thus, when administered at the onset of reperfusion following MCA occlusion, Mexidol exerts the most pronounced cerebroprotective effect, stimulating neurogenesis and suppressing the development of neuroinflammation and apoptosis.

Confidence: 0.18 · 9 полей извлечено
Идентификация (6 полей)
Target
BDNF
0.95
Alt. target
brain-derived neurotrophic factor
0.95
Protein family
neurotrophin
0.90
Functional class
growth factor
0.90
Subcellular loc.
—
0.00
Isoforms (metab/obesity)
—
0.00
Механизм действия (21 полей)
Mechanism
—
0.00
Mutations (obesity/lean)
—
0.00
Activity (obesity)
—
0.00
Activity temporal
—
0.00
Energy balance
—
0.00
Appetite
—
0.00
Fat metabolism
—
0.00
Lipolysis
—
0.00
Thermogenesis
—
0.00
Muscle metabolism
—
0.00
Inflammation
—
0.00
Glucose metabolism
—
0.00
AA metabolism
—
0.00
Hormonal pathways
—
0.00
Cell death
—
0.00
Adipocyte fibrosis
—
0.00
Upstream (biochem)
—
0.00
Upstream (physiol)
—
0.00
Downstream (biochem)
—
0.00
Downstream (physiol)
—
0.00
PTMs
—
0.00
Экспрессия (8 полей)
Tissue expression
—
0.00
In vitro
—
0.00
In vivo
Male Wistar rats subjected to right MCA occlusion-reperfusion (60 min occlusion) treated with Mexidol (50 mg/kg IV), Cerebrolysin (215 mg/kg IP), or Cortexin (1 mg/kg IP) at reperfusion onset. Outcomes assessed at 24h: brain lesion volume (TTC staining), BDNF, TNF-alpha, and apoptosis markers (Western blotting).
0.95
In silico
—
0.00
Genetic association
—
0.00
Ex vivo
—
0.00
Animal model
Male Wistar rats
1.00
Diet/model
Right MCA occlusion-reperfusion model (60 min occlusion, 24h reperfusion)
1.00
Клиника (11 полей)
Drug
Mexidol
0.90
Indication
acute cerebrovascular accidents
0.90
Patient subgroups
—
0.00
Safety concerns
—
0.00
Off-target
—
0.00
Trial stage
—
0.00
Pharma competitors
—
0.00
AE severity
—
0.00
MOA weight loss
—
0.00
Endpoints
—
0.00
Approved
—
0.00